ArticleTheranostics2022

Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling.

Xun Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.